dm+d

74074008

Refrigerated Storage

TracriumAspen

Aspen
Tracrium
10mg/mL solution for injection

In the event of an inadvertent temperature excursion the following data may be used:
Published data suggests ≤ 1% loss in potency per week at 25°C supporting storage at 25°C for 1 month.
No extended stability data provided by the manufacturer.
Contact Aspen in cases where additional stability data is required. Please refer to the manufacturer’s product literature for recommended storage information and company contact details at https://www.medicines.org.uk

15 September 2022
London MI Service

AtracuriumHameln

Hameln
Atracurium
10mg/mL solution for injection

Contact Hameln in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.

29 September 2022
London MI Service

AtracuriumConsilient Health

Consilient Health
Atracurium
10mg/mL solution for injection

In the event of an inadvertent temperature excursion the following data may be used:
Published data suggests ≤ 1% loss in potency per week at 25°C supporting storage at 25°C for 1 month.
No extended stability data provided by the manufacturer.
Contact Consilient Health in cases where additional stability data is required. Please refer to the manufacturer’s product literature for recommended storage information and company contact details at https://www.medicines.org.uk

15 September 2022
London MI Service

Atracurium BesilateHospira UK Ltd (part of Pfizer)

Hospira UK Ltd (part of Pfizer)
Atracurium Besilate
Solution for injection, 10mg/ml

In the event of an inadvertent temperature excursion the following data may be used:

Atracurium vials are stable when exposed to temperatures of up to 25°C for 1 month and -20°C for 1 month.

Atracurium ampoules are stable when exposed to temperatures of up to 25°C for 1 month.

Contact Pfizer in cases where additional stability data is required. Refer to the electronic medicines compendium (eMC) at medicines.org.uk for company contact details.

29 December 2021
London MI Service

AtracuriumAS Kalceks

AS Kalceks
Atracurium
10mg/mL solution for injection/infusion

In the event of an inadvertent temperature excursion the following data may be used:
Published data suggests ≤ 1% loss loss in potency per week at 25°C supporting storage at 25°C for 1 month.
No extended stability data provided by the manufacturer.
Contact AS Kalceks in cases where additional stability data is required. Please refer to the manufacturer’s product literature for recommended storage information and company contact details at https://www.medicines.org.uk.

15 September 2022
London MI Service

Lactation Safety Information

Yes
No published evidence of safety
Negligible levels anticipated in milk due to the drug’s properties
11 September 2020